RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $712 to $697.
- Headlines
- RBC Capital Maintains Outperform on Chemed, Lowers Price Target to $697
RBC Capital Maintains Outperform on Chemed, Lowers Price Target to $697
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
04:33
The development momentum of green bonds is strong, and policies promote great market development potential.
Bank Of China-1.09%
04:32
China's central bank will issue 60 billion yuan offshore central bank bills in Hong Kong. CITIC SEC's Mingming believes this can stabilize Exchange Rates market expectations to some extent.
04:26
The Israel Defense Forces stated that they intercepted the third Drone coming from Yemen during the night.